The NHS is urging more people to donate “liquid gold”, as Britain ramps up production of plasma for life-saving medicines.
4d
Did CSL's (ASX:CSL) Award-Winning Facility Redefine Its Innovation and Scale Investment Narrative?
In a landscape increasingly defined by technological advancements, CSL's Broadmeadows plasma fractionation facility has emerged as a beacon of innovation. Recently honored as the Overall Winner of the ...
Improvements in sensitivity, specificity, and accurate quantitation allow researchers to glean valuable information from hundreds of samples in record time.
CSL's Broadmeadows facility is purpose-built to enhance the production of plasma-derived therapies aimed at treating various conditions, including immunodeficiencies, neurological disorders, and ...
CSL's base fractionation facility in Broadmeadows, Australia has been recognised as the Overall Winner of the 2025 Facility ...
The International Society for Pharmaceutical Engineering (ISPE) has recognized CSL Behring as the Overall Winner of the 2025 ISPE Facility of the Year Awards (FOYA) for its Project Aurora Plasma Base ...
Three years ago, the company employed about 38 people. Today, the headcount is at 64, and the company is looking to expand ...
How do embryos develop? Why does the cortex of the mammalian brain fold? How do we feel touch at our fingertips? These and ...
China has achieved a significant breakthrough in developing key materials for controlled nuclear fusion, a crucial component ...
PRIME Project’s new whitepaper details how plasma-arc-melted GEN II Nitinol offers enhanced superelasticity, low hysteresis, ...
Q3 2025 Earnings Call October 29, 2025 10:00 AM EDTCompany ParticipantsJustine CarlsonEdward Lehner - President, CEO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback